The U.S. stock market has recently experienced a rebound, with investor attention shifting towards earnings reports and the Federal Reserve's policy decisions. Amidst these broader market movements, penny stocks remain an intriguing segment for investors seeking potential growth opportunities in smaller or newer companies. Although the term "penny stock" might seem outdated, it still signifies a relevant investment area where strong financial health can lead to significant returns.
Name | Share Price | Market Cap | Financial Health Rating |
QuantaSing Group (NasdaqGM:QSG) | $3.08 | $128.29M | ★★★★★★ |
BAB (OTCPK:BABB) | $0.86 | $6.22M | ★★★★★★ |
Kiora Pharmaceuticals (NasdaqCM:KPRX) | $3.80 | $11.49M | ★★★★★★ |
Inter & Co (NasdaqGS:INTR) | $4.97 | $2.18B | ★★★★☆☆ |
ZTEST Electronics (OTCPK:ZTST.F) | $0.2874 | $10.58M | ★★★★★★ |
Permianville Royalty Trust (NYSE:PVL) | $1.48 | $49.83M | ★★★★★★ |
Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
BTCS (NasdaqCM:BTCS) | $3.03 | $60.21M | ★★★★★★ |
Smith Micro Software (NasdaqCM:SMSI) | $1.30 | $23.41M | ★★★★★☆ |
CBAK Energy Technology (NasdaqCM:CBAT) | $0.8893 | $80.06M | ★★★★★☆ |
Click here to see the full list of 713 stocks from our US Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Cheche Group Inc. operates an auto insurance technology platform and has a market cap of approximately $69.30 million.
Operations: The company generates revenue primarily from its Insurance Brokers segment, totaling CN¥3.36 billion.
Market Cap: $69.3M
Cheche Group, with a market cap of US$69.30 million, operates an auto insurance technology platform and has shown signs of financial improvement despite challenges. The company reported third-quarter revenue of CN¥850.52 million and a net income turnaround to CN¥4.05 million from a previous loss, indicating potential recovery momentum. However, it faces compliance issues with Nasdaq's minimum bid price requirement but retains sufficient cash to cover liabilities and more than its total debt. Revenue growth is modest at 4.7%, while earnings are forecasted to grow significantly annually, suggesting potential value for risk-tolerant investors amidst volatility concerns and an inexperienced management team.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Dominari Holdings Inc., with a market cap of $11.05 million, operates through its subsidiaries in wealth management, investment banking, sales and trading, and asset management.
Operations: The company's revenue is primarily generated from the United States, amounting to $12.59 million.
Market Cap: $11.05M
Dominari Holdings Inc., with a market cap of US$11.05 million, is unprofitable but has shown revenue growth, reporting US$4.04 million in sales for Q3 2024 compared to US$0.963 million the previous year. Despite this, net losses increased to US$4.21 million from US$3.54 million year-over-year, highlighting ongoing financial challenges. The company maintains a strong balance sheet with short-term assets of US$24.8M exceeding liabilities and remains debt-free for five years, though it faces cash runway constraints under one year if current free cash flow trends persist. Recent board changes and shelf registration filings suggest strategic adjustments underway.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: IZEA Worldwide, Inc. operates by providing software and professional services that connect brands with content creators across North America, the Asia Pacific, and internationally, with a market cap of $45.13 million.
Operations: IZEA Worldwide generates revenue through two main segments: SaaS Services, contributing $0.82 million, and Managed Services, accounting for $32.95 million.
Market Cap: $45.13M
IZEA Worldwide, Inc., with a market cap of US$45.13 million, is unprofitable but maintains a solid financial position with short-term assets of US$62.7 million exceeding both its short and long-term liabilities. Despite reporting Q3 2024 sales of US$8.83 million, the company faced a net loss of US$8.77 million, partly due to a goodwill impairment charge of over $4 million. The management team is relatively new with an average tenure of 1.3 years; however, the board is seasoned with an average tenure exceeding 11 years. IZEA's revenue growth is forecasted at approximately 33% annually, supported by sufficient cash reserves for more than three years without debt concerns and recent strategic initiatives like shelf registration filings and potential acquisitions indicating future growth prospects.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:CCG NasdaqCM:DOMH and NasdaqCM:IZEA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。